-- Oppenheimer analysts reaffirmed Snowflake (NYSE:SNOW) as a top pick for 2025, driven by strong expectations for the company’s performance and strategic growth...
On Monday, shares of Delcath Systems, a specialty pharmaceutical company, leaped 8.9% in premarket trading following the announcement of preliminary revenue figures for the fourth...
By Vladimir Soldatkin MOSCOW (Reuters) - Sweeping U.S. sanctions on Russia's oil industry will make it more expensive for Moscow to sell its oil and complicate sea-borne crude...
This article summarizes the most significant insider buying and selling activities reported for US stocks on Friday. Top Buys: JELD-WEN (NYSE:JELD) Holding, Inc. (NYSE:JELD) saw...
-- The U.S. natural gas market is experiencing a surge of excitement not felt since 2014, with weather forecasts predicting January to be significantly colder than...
-- Emerging market (EM) equities remain under pressure, with JPMorgan strategists advising caution despite their underperformance and low valuation metrics. In a...
-- Shake Shack Inc . (NYSE: NYSE:SHAK) shares climbed 2% following the release of its preliminary unaudited results for the fiscal fourth quarter and fiscal year...
-- Pershing Square's Bill Ackman has proposed a merger between Howard Hughes Holdings Inc. (NYSE:HHH) and a subsidiary of Pershing Square Holdco, L.P. The proposal...
-- Moderna (NASDAQ:MRNA) has revised its revenue forecast for 2025, causing a decline in the company's share price. The biotechnology company now expects its 2025...
-- Shares of Amicus Therapeutics (NASDAQ:FOLD) jumped 9% as the biotech company provided an optimistic preliminary revenue outlook for 2024, along with expectations...